| 3-(cyclopropylMethoxy)-4-(difluoroMethoxy)benzoyl chloride |
3-(环丙基甲氧基)-4-(二氟甲氧基)苯甲酰氯 |
672883-68-0 |
| Valsartan Desvaleryl Impurity |
缬沙坦去戊酰基杂质 |
676129-92-3 |
| Bis[2-(di-i-propylphosphino)-4-methylphenyl]amine |
双[2-(二异丙基膦)-4-甲基苯基]胺 |
666856-94-6 |
| Linagliptin Impurity D |
利格列汀杂质D |
666816-91-7 |
| Olanzapine N-ForMyl IMpurity |
奥氮平N甲酰杂质 |
639460-79-0 |
| 2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl |
2-双环己基膦-2',6'-二甲氧基联苯 |
657408-07-6 |
| Nintedanib |
尼达尼布 |
656247-17-5 |
| BAY 61-3606 (dihydrochloride) |
BAY 61-3606 |
648903-57-5 |
| LY-404039 |
(1R,4S,5S,6S)-4-氨基-2-硫杂双环[3.1.0]己烷-4,6-二甲酸 2,2-二氧化物 |
635318-11-5 |
| GATIFLOXACIN RELATED COMPOUND A |
8-羟基基加替沙星 |
616205-76-6 |
| Argireline |
阿基瑞林 |
616204-22-9 |
| LorcaserinA |
8-氯-2,3,4,5-四氢-1-甲基-1H-3-苯并氮杂卓 |
616201-80-0 |
| 3-[[(tert-Butoxy)carbonyl]amino]-5-fluoro-4-oxopentanoic acid methyl ester |
3-[[叔丁氧羰基]氨基]-5-氟-4-氧代戊酸甲酯 |
634911-80-1 |
| Tasimelteon |
他司美琼 |
609799-22-6 |
| ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
沃拉帕沙杂质G |
618385-10-7 |
| MK-0822 |
(2S)-N-(1-氰基环丙基)-4-氟-4-甲基-2-[[(1S)-2,2,2-三氟-1-[4'-(甲基磺酰基)[1,1'-联苯]-4-基]乙基]氨基]戊酰胺 |
603139-19-1 |
| Bis[Tris(2-methylphenyl)phosphine]palladium |
双[三(2-甲苯基)膦]合钯 |
69861-71-8 |
| Cefuroxime Sodium EP Impurity C |
头孢呋辛钠EP杂质C |
69822-88-4 |
| rac trans-Hydroxy Glimepiride-D5 |
反式羟基格列美脲 |
600177-94-4 |
| 2,6-DIISOCYANATOHEXANOIC ACID 2-ISOCYANATOETHYL ESTER |
L-赖氨酸三异氰酸酯 |
69878-18-8 |
